HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 8,280.00
+130.00 (1.60%)
Aug 3, 2026, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 116.27 billion as of August 3, 2026. Its market cap has decreased by -47.59% in one year.
Market Cap
116.27B
Enterprise Value
116.72B
Revenue
236.59B
Ranking
n/a
PE Ratio
73.16
Stock Price
8,280.00
ChartMarket Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 116.27B, an increase of 37.96%. That is a compound annual growth rate of 3.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 116.27B | -48.38% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 148.35B |
| Ilsung Is | 140.08B |
| Jeil Pharmaceutical Co.,Ltd | 137.41B |
| Samil Pharmaceutical Co.,Ltd | 132.50B |
| Dongwha Pharm.Co.,Ltd | 129.72B |
| AptaBio Therapeutics | 129.09B |
| Kyongbo Pharmaceutical | 121.69B |
| SAMSUNG PHARM. Co., LTD. | 116.62B |